Bone Tumor Diagnosis and Treatments
Bone Tumor Diagnosis and Treatments is a research topic within Rheumatology. Science Explorer counts 34k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and molecular understanding of various bone tumors and tumor-like conditions in the skeletal system, including chondrosarcoma, chordoma, osteoid osteoma, giant cell tumor, fibrous dysplasia, aneurysmal bone cyst, Ollier disease, Maffucci syndrome, enchondroma, and mesenchymal chondrosarcoma.
- Chondrosarcoma
- Chordoma
- Osteoid Osteoma
- Giant Cell Tumor
- Fibrous Dysplasia
- Aneurysmal Bone Cyst
- Ollier Disease
- Maffucci Syndrome
- Enchondroma
- Mesenchymal Chondrosarcoma
- Research works
- 34k fractional, since 1950
- In the world top 10%
- 3.4k per year above
- Top-10% rate
- 10.0% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +2% the tick is no change
- Largest producer
United States
27% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Bone Tumor Diagnosis and Treatments research?
By volume, the United States and India publish the most (1k and 857 works in 2022-now).
By volume, 2022-now
- 1
United States 1k works
- 2
India 857 works
- 3
China 622 works
- 4
Japan 323 works
- 5
Türkiye 203 works
- 6
Brazil 199 works
- 7
Italy 183 works
- 8
United Kingdom 167 works
- 9
Germany 139 works
- 10
France 133 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Bone Tumor Diagnosis and Treatments research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Bone Tumor Diagnosis and Treatments research, followed by Harvard University and Peking University.
By volume, 2022-now
- 1
All India Institute of Medical Sciences
India 89 works
- 2
Harvard University
United States 45 works
- 3
Peking University
China 44 works
- 4
Mayo Clinic
United States 41 works
- 5
Sichuan University
China 30 works
- 6
Capital Medical University
China 28 works
- 7
Shanghai Jiao Tong University
China 28 works
- 8
Datta Meghe Institute of Higher Education and Research
India 23 works
- 9
The University of Texas MD Anderson Cancer Center
United States 22 works
- 10
Johns Hopkins University
United States 21 works
Who are the leading researchers in Bone Tumor Diagnosis and Treatments?
The most-cited researchers publishing on Bone Tumor Diagnosis and Treatments include Bert Vogelstein, Gad A. Getz and Cyrus Cooper.
- 1
Bert Vogelstein
United States 373k citations
- 2
Gad A. Getz
United States 364k citations
- 3
Cyrus Cooper
United Kingdom 342k citations
- 4
Jun Wang
China 340k citations
- 5
Dan J. Stein
South Africa 306k citations
- 6
Kenneth W. Kinzler
United States 253k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Bone Tumor Diagnosis and Treatments research done?
The largest centres of Bone Tumor Diagnosis and Treatments research in 2022-now are Beijing (China), New Delhi (India), Istanbul (Türkiye) and Chennai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Wardha and Rabat.
Largest cities, 2022-now
Where it is the local speciality
- WardhaIN · 24.8 works19×
- RabatMA · 29.5 works8.4×
Location quotient: how much more of its research is in Bone Tumor Diagnosis and Treatments than the world average.
Where is the best place to study Bone Tumor Diagnosis and Treatments?
Among universities, judged by research, Leiden University, Harvard University and All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Bone Tumor Diagnosis and Treatments, country by countryIs Bone Tumor Diagnosis and Treatments research growing?
Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Bone Tumor Diagnosis and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Bone Tumor Diagnosis and Treatments as a percentage of every work published that year, 0.024% in 2024.
Fractional works of Bone Tumor Diagnosis and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Bone Tumor Diagnosis and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.